Evaluation Study for a Non-Contact Biometer

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

95 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether a new non-contact biometer, is as accurate as the the available gold-standard.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The features of a not yet commercial available new biometer will be compared to available contact and non contact biometers in different patient groups.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cataract Pseudophakia Myopia Hyperopia Aphakia

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Biometry corneal opacity astigmatism refraction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. 18 year or older
2. Normal eye
3. Cataract
4. Corneal abnormality (scar, opacity, transplant)
5. refractive corneal surgery
6. Pseudophakia
7. Aphakia
8. Silicon oil
9. refractive IOL

2.-9. (at least one yes)

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

David Goldblum, MD

Role: PRINCIPAL_INVESTIGATOR

www.insel.ch

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Ophthalmology, University Hospital

Bern, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Insel 1351

Identifier Type: -

Identifier Source: secondary_id

kek-98/07